Estimating Melanoma Risk by Examining Skin’s Mutational Burden

By Cody R. Barnett, MRA Director of Communications | 10 February 2021 In Prevention, Science

 We’ve known for decades that most melanomas – formed from the color-producing cells in our skin called melanocytes – are predominantly caused by UV-radiation-induced damage from the sun or indoor tanning devices. This damage is cumulative but is often invisible.

Read More


Melanoma Models for the Next Decade of Progress

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 8 February 2021 In Science

Despite the tremendous progress that’s been made over the past decade for patients with melanoma, nearly half of patients do not benefit from currently approved therapies. Developing novel therapies for these individuals is a daunting challenge that begins with laboratory studies and hopefully ends with a drug candidate that is...

Read More


Personalized Vaccines for Melanoma – An Update

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 2 February 2021 In Science, Treatment

Vaccines work by priming the immune system, thereby reducing the severity and duration of symptoms or lowering the risk of becoming infected at all. And while vaccines have changed the world for infectious disease, did you know they can also help combat cancers.

Read More


Five Melanoma Research Highlights to Look Forward to in 2021

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 13 January 2021 In Allies & Partnerships, News, Prevention, Science, Treatment

At MRA, every day we are focused on how melanoma research can be reimagined to accelerate progress similar to what has been accomplished in record time with COVID-19 research, and look forward to a future not only void of COVID-19; but where suffering and death due to melanoma are no more.

Read More


Creating Art to Create Change: The Power to Heal & Mobilize Community

By Renee Orcione, MRA Development Associate | 11 January 2021 In Allies & Partnerships, Melanoma Stories

Following the initial shock of her diagnosis and the strain of facing treatments on her own, Barbara was faced with yet another hurdle. Her arm surgery had left it nearly immobile. Not only was this a problem for her daily functioning, it made it extremely difficult for Barbara to pursue her lifelong passion of art.

Read More


Reimagining Melanoma Research During and After the Pandemic

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 1 January 2021 In News, Science

The COVID-19 pandemic has touched all of our lives – from illnesses and unexpected deaths, to world economies and the careers impacted. Like everything else, melanoma research has also been impacted – from decreased enrollment in clinical trials, to research labs hampered by lock-downs and new protocols. At MRA, we contemplate how can melanoma research be reimagined to accelerate progress similar to what has been accomplished with COVID-19.

Read More


Exciting End of Year Melanoma Clinical Trial Results

By Kristen Mueller, Ph.D., MRA Scientific Program Director | 11 December 2020 In Science, Treatment

The annual Society for the Immunotherapy for Cancer (SITC) meeting did not disappoint, despite its virtual format, when it came to new clinical advances for melanoma. Researchers presented data from several important clinical trials and highlighted several novel agents that may boost responses to checkpoint immunotherapy.

Read More


Mary Jo Rogers: Research Will Get Us There

By Cody R. Barnett, MRA Director of Communications | 8 December 2020 In Melanoma Stories

With red hair and fair skin, Mary Jo Rogers has always known she was at high risk for melanoma, so she saw her dermatologist regularly. Despite knowing the risk, her 2011 diagnosis of Stage 3C melanoma still came as a big surprise.

Read More


Gail: Stage 4 to NED (No Evidence of Disease) Through a Clinical Trial

By Cody R. Barnett, MRA Director of Communications | 10 November 2020 In Melanoma Stories

Gail was already on her way out the exam room door, following her annual physical, before she remembered to ask about a dry cough she’d had for about a week.  

Read More


Amy Fights for Acral Melanoma to be Seen

By Cody R. Barnett, MRA Director of Communications | 28 October 2020 In Melanoma Stories

For patients diagnosed with acral melanoma today, Amy offers the following advice: “You aren’t alone. If you find a spot – any spot, really that looks different or concerns you – get it checked out. Advocate for a biopsy because doctors don’t always know what they are looking for when it comes to acral melanoma.”

Read More


Login

×